Biodefense Market
PUBLISHED: 2023 ID: SMRC23954
SHARE
SHARE

Biodefense Market

Biodefense Market Forecasts to 2030 - Global Analysis By Product (Anthrax, Botulism, Cholera, Influenza and Other Products), Detection Device, Application, End User and By Geography

4.6 (86 reviews)
4.6 (86 reviews)
Published: 2023 ID: SMRC23954

This report covers the impact of COVID-19 on this global market
Loading...

According to Stratistics MRC, the Global Biodefense Market is accounted for $16.2 billion in 2023 and is expected to reach $26.1 billion by 2030 growing at a CAGR of 7.0% during the forecast period. A system of precautions and responses put in place to guard against and address biological threats, notably those posed by biological weapons, bioterrorism, and naturally occurring infectious diseases, is referred to as "biodefense," which is short for "biological defense." The term "biodefense" refers to a broad range of initiatives, regulations, and procedures designed to protect human health, national security, and international peace and security. The goal of biodefense is to defend against dangers posed by biological agents, such as bacteria, viruses, poisons, and other microorganisms that can harm people, animals, or plants.

According to Federal Research and Development (R&D) Funding, the Department of Defense (39.3%) and the Department of Health and Human Services (27.3%) got 96.3% of the total funding obtained by eight federal agencies during the 2017 fiscal year.

Market Dynamics:

Driver:

Increasing emphasis on research and development

The building of a competent biodefense system as well as the preservation of human health both largely rely on new technology development. The on-going increase in clinical trials and increased R&D spending are two major factors fuelling the growth of the biodefense industry. For instance, a partnership agreement between Emergent Bio Solutions and the US government was signed in April 2020. The goal of this agreement was to make it easier to develop a plasma-derived treatment for COVID-19 patients. Additionally, Biomedical Advanced Research and Development Authority (BARDA), a section of the Office of the Assistant Secretary for Preparedness and Response (ASPR) at the U.S. Department of Health & Human Services (HHS), awarded Emergent USD to support its COVID-HIG program, one of two hyper immune development programs that Emergent announced. Hence all the initiatives on developing structured regulations and new molecules are driving the market.

Restraint:

Ethical considerations

In the subject of biodefense, which comprises attempts to safeguard public health, national security, and global stability against biological threats, such as bioterrorism and new infectious illnesses, ethical issues are of utmost importance. Policies, practices, and research in biodefense are guided by these ethical considerations, which seek to strike a balance between the requirement for readiness and morally righteous behaviour. Numerous biodefense research projects have the potential for dual use, which means they could be employed for both harmful and legitimately scientific objectives hinder the market.

Opportunity:

Beneficial government initiatives

Governments in industrialized countries take a number of actions and implement precautionary measures to be prepared to withstand these attacks. To safeguard the public, the government regularly maintains stocks of vaccines and tools for identifying biothreats. This is attributed to significant federal funding, technological advancements, and growing public awareness. The fact that major businesses are present here is also encouraging for the sector in the event of biological epidemics, the strategy aims to improve emergency response capabilities, stimulate and promote biomedical innovation, and locate and neutralize biothreats at their source. The regional biodefense market is being stimulated by these governmental actions.

Threat:

High cost

A sophisticated biodefense system, which includes research, development, stockpiling of medical countermeasures, and readiness measures, is costly to build and sustain. Programs for biodefense funding frequently face competition from healthcare and national security concerns. Moreover, dealing with a variety of biological threats and agents is part of biodefense. Creating defences against these many chemicals demands a high level of scientific and technical knowledge.

Covid-19 Impact

The COVID-19 has a big effect on the entire healthcare sector. According to an article from disaster medicine public health emergency from May 2022, the appearance of the COVID-19 pandemic has had a significant influence on people's lives as well as the stability of the economy and society. The study showed that there was a lack of testing and surveillance during the pandemic outbreak, which resulted in a widespread problem throughout the entire healthcare system. Bio threats are expected to remain challenging and significant risks to the United States and its international interests. COVID-19 consequently had an impact on the biodefense sector.

The anthrax segment is expected to be the largest during the forecast period

The anthrax segment is estimated to have a lucrative growth, because bacillus anthracis gram-positive, rod-shaped bacteria, is the source of the deadly infectious illness anthrax. Animals both domestic and wild are frequently impacted worldwide by this natural occurrence in soil. If people come into contact with diseased animals or contaminated animal products, they could become ill with anthrax. Raising awareness and ensuring that people and healthcare professionals understand the symptoms of anthrax and react correctly in the case of an outbreak or a bioterrorism incident are essential goals of public education programs are enhancing the biodefense market.

The assays segment is expected to have the highest CAGR during the forecast period

The assays segment is anticipated to witness the highest CAGR growth during the forecast period, as these are used to find, describe, and characterize biological agents and pathogens that could endanger the environment, national security, or public health, biodefense assays are specialized testing and analytical techniques. These tests are essential for monitoring, getting ready for, and responding to biological threats like bioterrorism and newly developing infectious illnesses. Mass spectrometry, flow cytometry, polymerase chain reaction (PCR), enzyme-linked immunosorbent assay (ELISA), and immunofluorescence these are a few assays that are used to identify hazards.

Region with largest share:

North America is projected to hold the largest market share during the forecast period owing to increased government initiatives and research and development in field studies are the main growth drivers of the biodefense market in North America. For instance, the National Health Security Strategy (NHSS) and National Biodefense Strategy (NBS) focused on advancing the United States health security enterprise through prevention, preparedness, response, recovery, and mitigation efforts to combat infectious disease and biological threats, according to the 2021 report from the National Association of County and City Health Officials. Moreover, The NBS and National Security Presidential Memorandum 14 also established a leadership structure and strategy to coordinate the full range of biodefense actions carried out across the U.S. Government in order to protect the American people from biological threats is driving the regions market growth.

Region with highest CAGR:

Asia Pacific is projected to have the highest CAGR over the forecast period, owing to rising R&D spending, and the growing importance of biodefense and the threat posed by dangerous biological materials that cause emergencies. Due to the presence of established facilities for the development of vaccines, Australia and Japan have two of the most developed biodefense industries in the Asia Pacific region. To prepare for future biological dangers, nations like China and India are aggressively enhancing their R&D capacities. These are the contributing factors which are propelling the biodefense market in this region.

Key players in the market

Some of the key players profiled in the Biodefense Market include Siga Technologies Inc., Emergent BioSolutions Inc., Ichor Medical Systems, National Resilience, Inc., Bavarian Nordic, Dynavax Technologies, Nighthawk Biosciences, Inc., XOMA Corporation Dynport Vaccine Company, Cleveland Biolabs, Ology Bioservices, Alnylam Pharmaceuticals Inc., XOMA Corporation, Altimmune Inc., Biosearch Technologies and Bruker Detection

Key Developments:

In August 2023, Emergent BioSolutions Announces Strategic Steps to Strengthen Core Business and Financial Position. Additionally, Emergent will reduce operations at its facility in Canton, Massachusetts, in response to changes in the volume of U.S. government procurements of medical countermeasures.

In July 2023, SIGA Technologies, Inc. a announced that the U.S. Department of Health and Human Services exercised procurement options for the delivery of approximately $113 million worth of oral TPOXX® treatment courses and approximately $25 million worth of IV TPOXX® treatment courses.

In July 2023, Emergent BioSolutions Inc. announced that the U.S. Food and Drug Administration (FDA) has approved CYFENDUS™ (Anthrax Vaccine Adsorbed, Adjuvanted), previously known as AV7909, for post-exposure prophylaxis of disease.

Products Covered:
• Anthrax
• Botulism
• Cholera
• Influenza
• Nuclear
• Smallpox
• Other Products

Detection Devices Covered:
• Assays
• Identifiers
• Samplers
• Detectors
• Triggering Devices
• Other Detection Devices

Applications Covered:
• Military
• Civilian

End Users Covered:
• Hospitals & Clinics
• Ambulatory Care Centers
• Government Institutions
• Other End Users

Regions Covered:
• North America
o US
o Canada
o Mexico
• Europe
o Germany
o UK
o Italy
o France
o Spain
o Rest of Europe
• Asia Pacific
o Japan
o China
o India
o Australia
o New Zealand
o South Korea
o Rest of Asia Pacific
• South America
o Argentina
o Brazil
o Chile
o Rest of South America
• Middle East & Africa
o Saudi Arabia
o UAE
o Qatar
o South Africa
o Rest of Middle East & Africa

What our report offers:
- Market share assessments for the regional and country-level segments
- Strategic recommendations for the new entrants
- Covers Market data for the years 2021, 2022, 2023, 2026, and 2030
- Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
- Strategic recommendations in key business segments based on the market estimations
- Competitive landscaping mapping the key common trends
- Company profiling with detailed strategies, financials, and recent developments
- Supply chain trends mapping the latest technological advancements

Free Customization Offerings:
All the customers of this report will be entitled to receive one of the following free customization options:
• Company Profiling
o Comprehensive profiling of additional market players (up to 3)
o SWOT Analysis of key players (up to 3)
• Regional Segmentation
o Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
• Competitive Benchmarking
o Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances

Table of Contents

1 Executive Summary

2 Preface
2.1 Abstract
2.2 Stake Holders
2.3 Research Scope
2.4 Research Methodology
2.4.1 Data Mining
2.4.2 Data Analysis
2.4.3 Data Validation
2.4.4 Research Approach
2.5 Research Sources
2.5.1 Primary Research Sources
2.5.2 Secondary Research Sources
2.5.3 Assumptions

3 Market Trend Analysis
3.1 Introduction
3.2 Drivers
3.3 Restraints
3.4 Opportunities
3.5 Threats
3.6 Product Analysis
3.7 Application Analysis
3.8 End User Analysis
3.9 Emerging Markets
3.10 Impact of Covid-19

4 Porters Five Force Analysis
4.1 Bargaining power of suppliers
4.2 Bargaining power of buyers
4.3 Threat of substitutes
4.4 Threat of new entrants
4.5 Competitive rivalry

5 Global Biodefense Market, By Product
5.1 Introduction
5.2 Anthrax
5.3 Botulism
5.4 Cholera
5.5 Influenza
5.6 Nuclear
5.7 Smallpox
5.8 Other Products

6 Global Biodefense Market, By Detection Device
6.1 Introduction
6.2 Assays
6.3 Identifiers
6.4 Samplers
6.5 Detectors
6.6 Triggering Devices
6.7 Other Detection Devices

7 Global Biodefense Market, By Application
7.1 Introduction
7.2 Military
7.3 Civilian

8 Global Biodefense Market, By End User
8.1 Introduction
8.2 Hospitals & Clinics
8.3 Ambulatory Care Centers
8.4 Government Institutions
8.5 Other End Users

9 Global Biodefense Market, By Geography
9.1 Introduction
9.2 North America
9.2.1 US
9.2.2 Canada
9.2.3 Mexico
9.3 Europe
9.3.1 Germany
9.3.2 UK
9.3.3 Italy
9.3.4 France
9.3.5 Spain
9.3.6 Rest of Europe
9.4 Asia Pacific
9.4.1 Japan
9.4.2 China
9.4.3 India
9.4.4 Australia
9.4.5 New Zealand
9.4.6 South Korea
9.4.7 Rest of Asia Pacific
9.5 South America
9.5.1 Argentina
9.5.2 Brazil
9.5.3 Chile
9.5.4 Rest of South America
9.6 Middle East & Africa
9.6.1 Saudi Arabia
9.6.2 UAE
9.6.3 Qatar
9.6.4 South Africa
9.6.5 Rest of Middle East & Africa

10 Key Developments
10.1 Agreements, Partnerships, Collaborations and Joint Ventures
10.2 Acquisitions & Mergers
10.3 New Product Launch
10.4 Expansions
10.5 Other Key Strategies

11 Company Profiling
11.1 Siga Technologies Inc.
11.2 Emergent BioSolutions Inc.
11.3 Ichor Medical Systems
11.4 National Resilience, Inc.
11.5 Bavarian Nordic
11.6 Dynavax Technologies
11.7 Nighthawk Biosciences, Inc.
11.8 XOMA Corporation
11.9 Dynport Vaccine Company
11.10 Cleveland Biolabs
11.11 Ology Bioservices
11.12 Alnylam Pharmaceuticals Inc.
11.13 XOMA corporation
11.14 Altimmune Inc.
11.15 Biosearch Technologies
11.16 Bruker Detection

List of Tables
1 Global Biodefense Market Outlook, By Region (2021-2030) ($MN)
2 Global Biodefense Market Outlook, By Product (2021-2030) ($MN)
3 Global Biodefense Market Outlook, By Anthrax (2021-2030) ($MN)
4 Global Biodefense Market Outlook, By Botulism (2021-2030) ($MN)
5 Global Biodefense Market Outlook, By Cholera (2021-2030) ($MN)
6 Global Biodefense Market Outlook, By Influenza (2021-2030) ($MN)
7 Global Biodefense Market Outlook, By Nuclear (2021-2030) ($MN)
8 Global Biodefense Market Outlook, By Smallpox (2021-2030) ($MN)
9 Global Biodefense Market Outlook, By Other Products (2021-2030) ($MN)
10 Global Biodefense Market Outlook, By Detection Device (2021-2030) ($MN)
11 Global Biodefense Market Outlook, By Assays (2021-2030) ($MN)
12 Global Biodefense Market Outlook, By Identifiers (2021-2030) ($MN)
13 Global Biodefense Market Outlook, By Samplers (2021-2030) ($MN)
14 Global Biodefense Market Outlook, By Detectors (2021-2030) ($MN)
15 Global Biodefense Market Outlook, By Triggering Devices (2021-2030) ($MN)
16 Global Biodefense Market Outlook, By Other Detection Devices (2021-2030) ($MN)
17 Global Biodefense Market Outlook, By Application (2021-2030) ($MN)
18 Global Biodefense Market Outlook, By Military (2021-2030) ($MN)
19 Global Biodefense Market Outlook, By Civilian (2021-2030) ($MN)
20 Global Biodefense Market Outlook, By End User (2021-2030) ($MN)
21 Global Biodefense Market Outlook, By Hospitals & Clinics (2021-2030) ($MN)
22 Global Biodefense Market Outlook, By Ambulatory Care Centers (2021-2030) ($MN)
23 Global Biodefense Market Outlook, By Government Institutions (2021-2030) ($MN)
24 Global Biodefense Market Outlook, By Other End Users (2021-2030) ($MN)
25 North America Biodefense Market Outlook, By Country (2021-2030) ($MN)
26 North America Biodefense Market Outlook, By Product (2021-2030) ($MN)
27 North America Biodefense Market Outlook, By Anthrax (2021-2030) ($MN)
28 North America Biodefense Market Outlook, By Botulism (2021-2030) ($MN)
29 North America Biodefense Market Outlook, By Cholera (2021-2030) ($MN)
30 North America Biodefense Market Outlook, By Influenza (2021-2030) ($MN)
31 North America Biodefense Market Outlook, By Nuclear (2021-2030) ($MN)
32 North America Biodefense Market Outlook, By Smallpox (2021-2030) ($MN)
33 North America Biodefense Market Outlook, By Other Products (2021-2030) ($MN)
34 North America Biodefense Market Outlook, By Detection Device (2021-2030) ($MN)
35 North America Biodefense Market Outlook, By Assays (2021-2030) ($MN)
36 North America Biodefense Market Outlook, By Identifiers (2021-2030) ($MN)
37 North America Biodefense Market Outlook, By Samplers (2021-2030) ($MN)
38 North America Biodefense Market Outlook, By Detectors (2021-2030) ($MN)
39 North America Biodefense Market Outlook, By Triggering Devices (2021-2030) ($MN)
40 North America Biodefense Market Outlook, By Other Detection Devices (2021-2030) ($MN)
41 North America Biodefense Market Outlook, By Application (2021-2030) ($MN)
42 North America Biodefense Market Outlook, By Military (2021-2030) ($MN)
43 North America Biodefense Market Outlook, By Civilian (2021-2030) ($MN)
44 North America Biodefense Market Outlook, By End User (2021-2030) ($MN)
45 North America Biodefense Market Outlook, By Hospitals & Clinics (2021-2030) ($MN)
46 North America Biodefense Market Outlook, By Ambulatory Care Centers (2021-2030) ($MN)
47 North America Biodefense Market Outlook, By Government Institutions (2021-2030) ($MN)
48 North America Biodefense Market Outlook, By Other End Users (2021-2030) ($MN)
49 Europe Biodefense Market Outlook, By Country (2021-2030) ($MN)
50 Europe Biodefense Market Outlook, By Product (2021-2030) ($MN)
51 Europe Biodefense Market Outlook, By Anthrax (2021-2030) ($MN)
52 Europe Biodefense Market Outlook, By Botulism (2021-2030) ($MN)
53 Europe Biodefense Market Outlook, By Cholera (2021-2030) ($MN)
54 Europe Biodefense Market Outlook, By Influenza (2021-2030) ($MN)
55 Europe Biodefense Market Outlook, By Nuclear (2021-2030) ($MN)
56 Europe Biodefense Market Outlook, By Smallpox (2021-2030) ($MN)
57 Europe Biodefense Market Outlook, By Other Products (2021-2030) ($MN)
58 Europe Biodefense Market Outlook, By Detection Device (2021-2030) ($MN)
59 Europe Biodefense Market Outlook, By Assays (2021-2030) ($MN)
60 Europe Biodefense Market Outlook, By Identifiers (2021-2030) ($MN)
61 Europe Biodefense Market Outlook, By Samplers (2021-2030) ($MN)
62 Europe Biodefense Market Outlook, By Detectors (2021-2030) ($MN)
63 Europe Biodefense Market Outlook, By Triggering Devices (2021-2030) ($MN)
64 Europe Biodefense Market Outlook, By Other Detection Devices (2021-2030) ($MN)
65 Europe Biodefense Market Outlook, By Application (2021-2030) ($MN)
66 Europe Biodefense Market Outlook, By Military (2021-2030) ($MN)
67 Europe Biodefense Market Outlook, By Civilian (2021-2030) ($MN)
68 Europe Biodefense Market Outlook, By End User (2021-2030) ($MN)
69 Europe Biodefense Market Outlook, By Hospitals & Clinics (2021-2030) ($MN)
70 Europe Biodefense Market Outlook, By Ambulatory Care Centers (2021-2030) ($MN)
71 Europe Biodefense Market Outlook, By Government Institutions (2021-2030) ($MN)
72 Europe Biodefense Market Outlook, By Other End Users (2021-2030) ($MN)
73 Asia Pacific Biodefense Market Outlook, By Country (2021-2030) ($MN)
74 Asia Pacific Biodefense Market Outlook, By Product (2021-2030) ($MN)
75 Asia Pacific Biodefense Market Outlook, By Anthrax (2021-2030) ($MN)
76 Asia Pacific Biodefense Market Outlook, By Botulism (2021-2030) ($MN)
77 Asia Pacific Biodefense Market Outlook, By Cholera (2021-2030) ($MN)
78 Asia Pacific Biodefense Market Outlook, By Influenza (2021-2030) ($MN)
79 Asia Pacific Biodefense Market Outlook, By Nuclear (2021-2030) ($MN)
80 Asia Pacific Biodefense Market Outlook, By Smallpox (2021-2030) ($MN)
81 Asia Pacific Biodefense Market Outlook, By Other Products (2021-2030) ($MN)
82 Asia Pacific Biodefense Market Outlook, By Detection Device (2021-2030) ($MN)
83 Asia Pacific Biodefense Market Outlook, By Assays (2021-2030) ($MN)
84 Asia Pacific Biodefense Market Outlook, By Identifiers (2021-2030) ($MN)
85 Asia Pacific Biodefense Market Outlook, By Samplers (2021-2030) ($MN)
86 Asia Pacific Biodefense Market Outlook, By Detectors (2021-2030) ($MN)
87 Asia Pacific Biodefense Market Outlook, By Triggering Devices (2021-2030) ($MN)
88 Asia Pacific Biodefense Market Outlook, By Other Detection Devices (2021-2030) ($MN)
89 Asia Pacific Biodefense Market Outlook, By Application (2021-2030) ($MN)
90 Asia Pacific Biodefense Market Outlook, By Military (2021-2030) ($MN)
91 Asia Pacific Biodefense Market Outlook, By Civilian (2021-2030) ($MN)
92 Asia Pacific Biodefense Market Outlook, By End User (2021-2030) ($MN)
93 Asia Pacific Biodefense Market Outlook, By Hospitals & Clinics (2021-2030) ($MN)
94 Asia Pacific Biodefense Market Outlook, By Ambulatory Care Centers (2021-2030) ($MN)
95 Asia Pacific Biodefense Market Outlook, By Government Institutions (2021-2030) ($MN)
96 Asia Pacific Biodefense Market Outlook, By Other End Users (2021-2030) ($MN)
97 South America Biodefense Market Outlook, By Country (2021-2030) ($MN)
98 South America Biodefense Market Outlook, By Product (2021-2030) ($MN)
99 South America Biodefense Market Outlook, By Anthrax (2021-2030) ($MN)
100 South America Biodefense Market Outlook, By Botulism (2021-2030) ($MN)
101 South America Biodefense Market Outlook, By Cholera (2021-2030) ($MN)
102 South America Biodefense Market Outlook, By Influenza (2021-2030) ($MN)
103 South America Biodefense Market Outlook, By Nuclear (2021-2030) ($MN)
104 South America Biodefense Market Outlook, By Smallpox (2021-2030) ($MN)
105 South America Biodefense Market Outlook, By Other Products (2021-2030) ($MN)
106 South America Biodefense Market Outlook, By Detection Device (2021-2030) ($MN)
107 South America Biodefense Market Outlook, By Assays (2021-2030) ($MN)
108 South America Biodefense Market Outlook, By Identifiers (2021-2030) ($MN)
109 South America Biodefense Market Outlook, By Samplers (2021-2030) ($MN)
110 South America Biodefense Market Outlook, By Detectors (2021-2030) ($MN)
111 South America Biodefense Market Outlook, By Triggering Devices (2021-2030) ($MN)
112 South America Biodefense Market Outlook, By Other Detection Devices (2021-2030) ($MN)
113 South America Biodefense Market Outlook, By Application (2021-2030) ($MN)
114 South America Biodefense Market Outlook, By Military (2021-2030) ($MN)
115 South America Biodefense Market Outlook, By Civilian (2021-2030) ($MN)
116 South America Biodefense Market Outlook, By End User (2021-2030) ($MN)
117 South America Biodefense Market Outlook, By Hospitals & Clinics (2021-2030) ($MN)
118 South America Biodefense Market Outlook, By Ambulatory Care Centers (2021-2030) ($MN)
119 South America Biodefense Market Outlook, By Government Institutions (2021-2030) ($MN)
120 South America Biodefense Market Outlook, By Other End Users (2021-2030) ($MN)
121 Middle East & Africa Biodefense Market Outlook, By Country (2021-2030) ($MN)
122 Middle East & Africa Biodefense Market Outlook, By Product (2021-2030) ($MN)
123 Middle East & Africa Biodefense Market Outlook, By Anthrax (2021-2030) ($MN)
124 Middle East & Africa Biodefense Market Outlook, By Botulism (2021-2030) ($MN)
125 Middle East & Africa Biodefense Market Outlook, By Cholera (2021-2030) ($MN)
126 Middle East & Africa Biodefense Market Outlook, By Influenza (2021-2030) ($MN)
127 Middle East & Africa Biodefense Market Outlook, By Nuclear (2021-2030) ($MN)
128 Middle East & Africa Biodefense Market Outlook, By Smallpox (2021-2030) ($MN)
129 Middle East & Africa Biodefense Market Outlook, By Other Products (2021-2030) ($MN)
130 Middle East & Africa Biodefense Market Outlook, By Detection Device (2021-2030) ($MN)
131 Middle East & Africa Biodefense Market Outlook, By Assays (2021-2030) ($MN)
132 Middle East & Africa Biodefense Market Outlook, By Identifiers (2021-2030) ($MN)
133 Middle East & Africa Biodefense Market Outlook, By Samplers (2021-2030) ($MN)
134 Middle East & Africa Biodefense Market Outlook, By Detectors (2021-2030) ($MN)
135 Middle East & Africa Biodefense Market Outlook, By Triggering Devices (2021-2030) ($MN)
136 Middle East & Africa Biodefense Market Outlook, By Other Detection Devices (2021-2030) ($MN)
137 Middle East & Africa Biodefense Market Outlook, By Application (2021-2030) ($MN)
138 Middle East & Africa Biodefense Market Outlook, By Military (2021-2030) ($MN)
139 Middle East & Africa Biodefense Market Outlook, By Civilian (2021-2030) ($MN)
140 Middle East & Africa Biodefense Market Outlook, By End User (2021-2030) ($MN)
141 Middle East & Africa Biodefense Market Outlook, By Hospitals & Clinics (2021-2030) ($MN)
142 Middle East & Africa Biodefense Market Outlook, By Ambulatory Care Centers (2021-2030) ($MN)
143 Middle East & Africa Biodefense Market Outlook, By Government Institutions (2021-2030) ($MN)
144 Middle East & Africa Biodefense Market Outlook, By Other End Users (2021-2030) ($MN)

List of Figures

List of Figures
Figure 1 Global Biodefense Market Outlook (2021-2030) ($MN)
Figure 2 North America Biodefense Market Outlook (2021-2030) ($MN)
Figure 3 US Biodefense Market Outlook (2021-2030) ($MN)
Figure 4 Canada Biodefense Market Outlook (2021-2030) ($MN)
Figure 5 Mexico Biodefense Market Outlook (2021-2030) ($MN)
Figure 6 Europe Biodefense Market Outlook (2021-2030) ($MN)
Figure 7 Germany Biodefense Market Outlook (2021-2030) ($MN)
Figure 8 UK Biodefense Market Outlook (2021-2030) ($MN)
Figure 9 Italy Biodefense Market Outlook (2021-2030) ($MN)
Figure 10 France Biodefense Market Outlook (2021-2030) ($MN)
Figure 11 Spain Biodefense Market Outlook (2021-2030) ($MN)
Figure 12 Rest of Europe Biodefense Market Outlook (2021-2030) ($MN)
Figure 13 Asia Pacific Biodefense Market Outlook (2021-2030) ($MN)
Figure 14 Japan Biodefense Market Outlook (2021-2030) ($MN)
Figure 15 China Biodefense Market Outlook (2021-2030) ($MN)
Figure 16 India Biodefense Market Outlook (2021-2030) ($MN)
Figure 17 Australia Biodefense Market Outlook (2021-2030) ($MN)
Figure 18 New Zealand Biodefense Market Outlook (2021-2030) ($MN)
Figure 19 South Korea Biodefense Market Outlook (2021-2030) ($MN)
Figure 20 Rest of Asia Pacific Biodefense Market Outlook (2021-2030) ($MN)
Figure 21 South America Biodefense Market Outlook (2021-2030) ($MN)
Figure 22 Argentina Biodefense Market Outlook (2021-2030) ($MN)
Figure 23 Brazil Biodefense Market Outlook (2021-2030) ($MN)
Figure 24 Chile Biodefense Market Outlook (2021-2030) ($MN)
Figure 25 Rest of South America Biodefense Market Outlook (2021-2030) ($MN)
Figure 26 Middle East & Africa Biodefense Market Outlook (2021-2030) ($MN)
Figure 27 Saudi Arabia Biodefense Market Outlook (2021-2030) ($MN)
Figure 28 UAE Biodefense Market Outlook (2021-2030) ($MN)
Figure 29 Qatar Biodefense Market Outlook (2021-2030) ($MN)
Figure 30 South Africa Biodefense Market Outlook (2021-2030) ($MN)
Figure 31 Rest of Middle East & Africa Biodefense Market Outlook (2021-2030) ($MN)

 

RESEARCH METHODOLOGY


Research Methodology

We at Stratistics opt for an extensive research approach which involves data mining, data validation, and data analysis. The various research sources include in-house repository, secondary research, competitor’s sources, social media research, client internal data, and primary research.

Our team of analysts prefers the most reliable and authenticated data sources in order to perform the comprehensive literature search. With access to most of the authenticated data bases our team highly considers the best mix of information through various sources to obtain extensive and accurate analysis.

Each report takes an average time of a month and a team of 4 industry analysts. The time may vary depending on the scope and data availability of the desired market report. The various parameters used in the market assessment are standardized in order to enhance the data accuracy.

Data Mining

The data is collected from several authenticated, reliable, paid and unpaid sources and is filtered depending on the scope & objective of the research. Our reports repository acts as an added advantage in this procedure. Data gathering from the raw material suppliers, distributors and the manufacturers is performed on a regular basis, this helps in the comprehensive understanding of the products value chain. Apart from the above mentioned sources the data is also collected from the industry consultants to ensure the objective of the study is in the right direction.

Market trends such as technological advancements, regulatory affairs, market dynamics (Drivers, Restraints, Opportunities and Challenges) are obtained from scientific journals, market related national & international associations and organizations.

Data Analysis

From the data that is collected depending on the scope & objective of the research the data is subjected for the analysis. The critical steps that we follow for the data analysis include:

  • Product Lifecycle Analysis
  • Competitor analysis
  • Risk analysis
  • Porters Analysis
  • PESTEL Analysis
  • SWOT Analysis

The data engineering is performed by the core industry experts considering both the Marketing Mix Modeling and the Demand Forecasting. The marketing mix modeling makes use of multiple-regression techniques to predict the optimal mix of marketing variables. Regression factor is based on a number of variables and how they relate to an outcome such as sales or profits.


Data Validation

The data validation is performed by the exhaustive primary research from the expert interviews. This includes telephonic interviews, focus groups, face to face interviews, and questionnaires to validate our research from all aspects. The industry experts we approach come from the leading firms, involved in the supply chain ranging from the suppliers, distributors to the manufacturers and consumers so as to ensure an unbiased analysis.

We are in touch with more than 15,000 industry experts with the right mix of consultants, CEO's, presidents, vice presidents, managers, experts from both supply side and demand side, executives and so on.

The data validation involves the primary research from the industry experts belonging to:

  • Leading Companies
  • Suppliers & Distributors
  • Manufacturers
  • Consumers
  • Industry/Strategic Consultants

Apart from the data validation the primary research also helps in performing the fill gap research, i.e. providing solutions for the unmet needs of the research which helps in enhancing the reports quality.


For more details about research methodology, kindly write to us at info@strategymrc.com

Frequently Asked Questions

In case of any queries regarding this report, you can contact the customer service by filing the “Inquiry Before Buy” form available on the right hand side. You may also contact us through email: info@strategymrc.com or phone: +1-301-202-5929

Yes, the samples are available for all the published reports. You can request them by filling the “Request Sample” option available in this page.

Yes, you can request a sample with your specific requirements. All the customized samples will be provided as per the requirement with the real data masked.

All our reports are available in Digital PDF format. In case if you require them in any other formats, such as PPT, Excel etc you can submit a request through “Inquiry Before Buy” form available on the right hand side. You may also contact us through email: info@strategymrc.com or phone: +1-301-202-5929

We offer a free 15% customization with every purchase. This requirement can be fulfilled for both pre and post sale. You may send your customization requirements through email at info@strategymrc.com or call us on +1-301-202-5929.

We have 3 different licensing options available in electronic format.

  • Single User Licence: Allows one person, typically the buyer, to have access to the ordered product. The ordered product cannot be distributed to anyone else.
  • 2-5 User Licence: Allows the ordered product to be shared among a maximum of 5 people within your organisation.
  • Corporate License: Allows the product to be shared among all employees of your organisation regardless of their geographical location.

All our reports are typically be emailed to you as an attachment.

To order any available report you need to register on our website. The payment can be made either through CCAvenue or PayPal payments gateways which accept all international cards.

We extend our support to 6 months post sale. A post sale customization is also provided to cover your unmet needs in the report.

Request Customization

We provide a free 15% customization on every purchase. This requirement can be fulfilled for both pre and post sale. You may send your customization requirements through email at info@strategymrc.com or call us on +1-301-202-5929.

Note: This customization is absolutely free until it falls under the 15% bracket. If your requirement exceeds this a feasibility check will be performed. Post that, a quote will be provided along with the timelines.

WHY CHOOSE US ?

Assured Quality

Assured Quality

Best in class reports with high standard of research integrity

24X7 Research Support

24X7 Research Support

Continuous support to ensure the best customer experience.

Free Customization

Free Customization

Adding more values to your product of interest.

Safe and Secure Access

Safe & Secure Access

Providing a secured environment for all online transactions.

Trusted by 600+ Brands

Trusted by 600+ Brands

Serving the most reputed brands across the world.

Testimonials